Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3284385 | Clinical Gastroenterology and Hepatology | 2010 | 7 Pages |
Abstract
Early discontinuation of antiviral therapy is common. Use of growth factors was the strongest independent predictor of treatment retention before 24 weeks and should be evaluated prospectively. Early interventions may also be warranted for other risk factors for early discontinuation, such as pre-existing substance use, depression, cirrhosis, or diabetes.
Keywords
FTEInternational Classification of Diseases 9th Revisiontreatment attritionEVRICD-9SVRSubstance use disorderVeterans affairsSUDbody mass indexBMITreatment durationHCVHepatitis C virusViral hepatitishuman immunodeficiency virusHIVearly virologic responseSustained virologic responseHepatologyGastroenterology
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Lauren A. Beste, George N. Ioannou, Meaghan S. Larson, Michael Chapko, Jason A. Dominitz,